🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 7 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/12/2020 22,98 23,59 20,75 21,37 -7,29% 12,36% 600.500
28/12/2020 24,00 24,03 22,27 23,05 -2,95% 7,33% 566.600
24/12/2020 23,89 24,53 23,36 23,75 -0,63% 4,90% 141.000
23/12/2020 25,59 25,59 23,33 23,90 -4,89% 8,83% 591.600
22/12/2020 23,48 25,65 23,31 25,13 +6,98% 9,96% 651.300
21/12/2020 20,85 23,63 20,22 23,49 +11,22% 16,35% 469.500
18/12/2020 21,01 21,68 19,88 21,12 +3,43% 8,57% 1.335.100
17/12/2020 21,88 21,98 20,20 20,42 -5,94% 8,11% 340.000
16/12/2020 21,02 22,00 20,30 21,71 +9,87% 8,09% 997.000
15/12/2020 21,07 21,10 19,48 19,76 -5,54% 7,69% 590.600
14/12/2020 21,89 22,33 20,78 20,92 -2,79% 7,08% 750.700
11/12/2020 23,42 23,91 20,89 21,52 -0,19% 12,89% 2.400.000
10/12/2020 21,89 22,24 20,62 21,56 -8,02% 7,40% 504.800
09/12/2020 24,48 24,48 22,50 23,44 -4,13% 8,09% 349.000
08/12/2020 22,91 24,50 22,38 24,45 +6,72% 9,28% 225.100
07/12/2020 23,17 23,90 22,61 22,91 +2,25% 5,57% 384.600
04/12/2020 21,29 22,41 21,07 22,41 +5,19% 6,29% 293.500
03/12/2020 21,68 22,86 21,04 21,30 -3,14% 8,38% 235.900
02/12/2020 23,45 23,45 21,51 21,99 -5,09% 8,27% 239.400
01/12/2020 24,02 24,90 22,90 23,17 -4,10% 8,33% 405.200
30/11/2020 24,08 24,73 22,79 24,16 +1,30% 8,06% 704.500
27/11/2020 23,49 24,96 23,20 23,85 +3,11% 7,49% 218.500
25/11/2020 22,51 23,61 22,05 23,13 +4,05% 6,93% 157.500
24/11/2020 22,03 22,80 21,67 22,23 +0,82% 5,13% 325.800
23/11/2020 21,99 22,60 21,60 22,05 +1,47% 4,55% 185.100
20/11/2020 21,25 21,87 20,30 21,73 +1,07% 7,39% 464.500
19/11/2020 22,19 23,75 21,00 21,50 -3,02% 12,38% 266.100
18/11/2020 21,59 23,14 21,44 22,17 +1,42% 7,87% 1.312.300
17/11/2020 21,76 22,15 21,36 21,86 -0,46% 3,61% 380.000
16/11/2020 22,56 22,79 21,46 21,96 -1,13% 5,90% 365.400